glp-1 tired Unexpected Side Effects of GLP-1s glp 1 chronic fatigue syndrome

The mechanism is under investigation but likely related to glucagon receptor activation

IDO1 inhibitors have been tested in a variety of anti-cancer treatments, including epacadostat (Table 1), indoximod, and navoximod, but compared with the results of preclinical trials, the efficacy of IDO1 inhibitors alone have not been objectively reflected in the clinical trials (Soliman et al., 2016

Diabetes Obes Metab (2011) 13(4):3747

Large meals combined with delayed emptying is the primary trigger for nausea

The side effect comparison between semaglutide and tirzepatide provides additional context on GLP-1 tolerability patterns